[7] [14] Participants receiving higher doses of retatrutide (particularly 8 mg and 12 mg weekly) experienced mean increases in heart rate of approximately 5 to 7 beats per minute (bpm) above baseline, based on data reported in the 2023 NEJM Phase 2 publications
Aunque los efectos secundarios como nuseas suelen aparecer en las primeras 4-8 semanas, la mayora de los pacientes nota que estos sntomas disminuyen mucho despus de la semana 12
While mild dizziness during the initial adjustment period may be common, certain symptoms warrant prompt medical evaluation
Whole-food supplements help bridge that gap
To view a copy of this licence, visit About this article Cite this article Fors, A., Forslund, T., Sundstrm, A
Research-vial material is not an approved drug, is not manufactured to sterile-injectable standards, and is sold research-use-only